Federal regulators fined a practice management software and services vendor $350,000 in the aftermath of an investigation into a 2018 HIPAA breach that involved a
Coherus BioSciences (NASDAQ:CHRS – Get Rating) had its price objective trimmed by Maxim Group from $15.00 to $12.00 in a report issued on Friday, The Fly reports. A number of other analysts have also recently issued reports on the company. StockNews.com began coverage on Coherus BioSciences in a report on Thursday, March 16th. They set […]
Cloud-based electronic health records vendor NextGen Healthcare is so far facing a dozen proposed class action lawsuits filed in the last week in the same Georgia
Federal regulators fined a practice management software and services vendor $350,000 in the aftermath of an investigation into a 2018 HIPAA breach that involved a
Coherus BioSciences (NASDAQ:CHRS – Get Rating) had its price target lowered by Maxim Group from $15.00 to $12.00 in a report released on Friday morning, The Fly reports. A number of other equities research analysts also recently weighed in on the stock. UBS Group upgraded shares of Coherus BioSciences from a neutral rating to a […]